Creation of the Biobank Related to Eye Disease
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Eye Diseases
- Sponsor
- Kimberly Drenser
- Enrollment
- 669
- Locations
- 1
- Primary Endpoint
- To build the platform for a novel application of translational research that links cutting edge molecular laboratory techniques to clinical outcome studies
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
The purpose of this study is to develop a BioBank (a specialized lab) and collect blood, fluids and/or other tissue samples to study eye diseases.
Detailed Description
The purpose of the Biobank related to eye disease at Beaumont Hospital is to help connect specialties and Specialists with each other, outside traditional limits of hospital or laboratory departments. The specimens (blood, fluids, and/or tissue samples) that will be collected from men, women and children will assist the researchers in a variety of studies on human eye diseases. Research utilizing these specimens will allow for an increased understanding of the etiology, disease process, and response to treatments for various eye diseases, and will provide opportunities to subsequently improve our management decisions. Furthermore, projects that cross over between subspecialties are sparse and that is a limiting factor for the development of research that takes a more comprehensive approach.
Investigators
Kimberly Drenser
M.D, Ph.D.
William Beaumont Hospitals
Eligibility Criteria
Inclusion Criteria
- •All pediatric and adult patients age 0-99 years -
Exclusion Criteria
- •All patients who do not agree to consent for collection of blood, fluids, tissue.
- •Patients who are cognitively impaired and are not able to verbalize understanding of the risks/benefits.
Outcomes
Primary Outcomes
To build the platform for a novel application of translational research that links cutting edge molecular laboratory techniques to clinical outcome studies
Biobanks can be used for numberous discovery applications such as: identification and structural characterization of human genes, expression analysis, or discovery proteomics. Biological specimens, when coupled with standardized treatment and outcome data, will be essential resources for the identification, characterization and validation of biomarkers that are predictive of disease and treatment.